Rapid Deletion and Inactivation of CTLs upon Recognition of a Number of Target Cells over a Critical Threshold

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Immunology

• Publication date

  2013-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.1300803PMID 24018271
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Trial Watch

  2013cited by this paper
• Marginating dendritic cells of the tumor microenvironment cross-present tumor antigens and stably engage tumor-specific T cells.

  2012cited by this paper
• Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation

  2012cited by this paper
• Transcriptional regulator early growth response gene 2 (Egr2) is required for T cell anergy in vitro and in vivo

  2012influential reference
• Adoptive cellular therapy.

  2011cited by this paper
• Induction of antigen‐specific effector‐phase tolerance following vaccination against a previously ignored B‐cell lymphoma

  2011influential reference
• Expression of tumour-specific antigens underlies cancer immunoediting

  2011cited by this paper
• CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens.

  2011cited by this paper
• CD8+ T Cells: Foot Soldiers of the Immune System

  2011influential reference
• Defects in the Bcl-2–Regulated Apoptotic Pathway Lead to Preferential Increase of CD25lowFoxp3+ Anergic CD4+ T Cells

  2011cited by this paper
• Cell transfer immunotherapy for metastatic solid cancer—what clinicians need to know

  2011cited by this paper
• High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cells.

  2011cited by this paper
• T cell exhaustion

  2011cited by this paper
• Autoimmunity associated with immunotherapy of cancer.

  2011cited by this paper
• Are senescence and exhaustion intertwined or unrelated processes that compromise immunity?

  2011cited by this paper
• Cell death in the maintenance and abrogation of tolerance: the five Ws of dying cells.

  2011cited by this paper
• Tumor-infiltrating NY-ESO-1–specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer

  2010cited by this paper
• Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells

  2010cited by this paper
• Features of responding T cells in cancer and chronic infection.

  2010cited by this paper
• CD8+ T cell concentration determines their efficiency in killing cognate antigen–expressing syngeneic mammalian cells in vitro and in mouse tissues

  2010cited by this paper
• Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+ T cell dysfunction in melanoma patients

  2010cited by this paper
• Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

  2010cited by this paper
• Adoptive T cell therapy of cancer.

  2010cited by this paper
• CD8α+ DC are not the sole subset cross‐presenting cell‐associated tumor antigens from a solid tumor

  2010cited by this paper
• Targeting Antigen to Diverse APCs Inactivates Memory CD8+ T Cells without Eliciting Tissue-Destructive Effector Function

  2009influential reference
• Tissue destruction caused by cytotoxic T lymphocytes induces deletional tolerance

  2009cited by this paper
• Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity

  2009cited by this paper
• Myeloid-derived suppressor cells as regulators of the immune system

  2009cited by this paper
• High antigen levels are the cause of T cell exhaustion during chronic viral infection

  2009influential reference
• PD-1 and its ligands in tolerance and immunity.

  2008cited by this paper
• Adoptive cell transfer: a clinical path to effective cancer immunotherapy

  2008cited by this paper
• Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells.

  2008cited by this paper
• Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity.

  2008cited by this paper
• T-cell death and cancer immune tolerance

  2008cited by this paper
• Batf3 Deficiency Reveals a Critical Role for CD8α+ Dendritic Cells in Cytotoxic T Cell Immunity

  2008cited by this paper
• Antigen-presentation properties of plasmacytoid dendritic cells.

  2008cited by this paper
• The cell biology of cross‐presentation and the role of dendritic cell subsets

  2008cited by this paper
• Two-photon imaging of intratumoral CD8+ T cell cytotoxic activity during adoptive T cell therapy in mice.

  2008cited by this paper
• Cancer immunotherapy by dendritic cells.

  2008cited by this paper
• Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer

  2007cited by this paper
• In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor

  2007cited by this paper
• Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo

  2007cited by this paper
• Adoptive T cell therapy for cancer in the clinic.

  2007cited by this paper
• In vivo imaging of T cell delivery to tumors after adoptive transfer therapy

  2007cited by this paper
• Restoring function in exhausted CD8 T cells during chronic viral infection

  2006cited by this paper
• Random migration precedes stable target cell interactions of tumor-infiltrating T cells

  2006cited by this paper
• Most lymphoid organ dendritic cell types are phenotypically and functionally immature.

  2003cited by this paper
• T-cell-receptor gene therapy

  2002cited by this paper
• Characterization of two TCR transgenic mouse lines specific for herpes simplex virus

  2002cited by this paper
• The Dendritic Cell Populations of Mouse Lymph Nodes1

  2001cited by this paper
• Adoptive cellular therapy.

  2000cited by this paper
• CD4 and CD8 Expression by Dendritic Cell Subtypes in Mouse Thymus and Spleen1

  2000cited by this paper
• Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes.

  1997cited by this paper
• HLA-A2.1–restricted Education and Cytolytic Activity of CD8+ T Lymphocytes from β2 Microglobulin (β2m) HLA-A2.1 Monochain Transgenic H-2Db β2m Double Knockout Mice

  1997cited by this paper
• T cell receptor antagonist peptides induce positive selection.

  1994cited by this paper
• The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro

  1994cited by this paper
• Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.

  1993cited by this paper
• Microenvironment and Immunology Immune Inhibitory Molecules Lag-3 and Pd-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape

  year unknowncited by this paper

• HDACi-dependent microenvironmental normalization overcomes tumor burden-induced T-cell exhaustion.

  2023cites this paper
• Implications of High Tumor Burden on Chimeric Antigen Receptor T-Cell Immunotherapy: A Review.

  2023cites this paper
• A Specific CD44lo CD25lo Subpopulation of Regulatory T Cells Inhibits Anti-Leukemic Immune Response and Promotes the Progression in a Mouse Model of Chronic Lymphocytic Leukemia

  2022cites this paper
• Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical Efficacy

  2021cites this paper
• Tumor Burden and Immunotherapy: Impact on Immune Infiltration and Therapeutic Outcomes

  2021cites this paper
• Étude de la répartition asymétrique des molécules lytiques et métaboliques dans la division des lymphocytes T CD8+ humains

  2018cites this paper
• Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4+Foxp3− Cell–Mediated Modulation of CD103+ Dendritic Cells

  2018cites this paper
• Converting Lymphoma Cells into Potent Antigen-Presenting Cells for Interferon-Induced Tumor Regression

  2017cites this paper
• 2B4-SAP signaling is required for the priming of naive CD8+ T cells by antigen-expressing B cells and B lymphoma cells

  2017cites this paper
• Target Density, Not Affinity or Avidity of Antigen Recognition, Determines Adoptive T Cell Therapy Outcomes in a Mouse Lymphoma Model

  2016cites this paper
• Two Heads Are Better Than One: The Combination of Dendritic Cells & B Cells Yields An Improved T Cell Response Over Dendritic Cells Alone When Presenting Tumour Lysate Antigens

  2016cites this paper
• Antigen‐specific impairment of adoptive T‐cell therapy against cancer: players, mechanisms, solutions and a hypothesis

  2016influential citation
• Combining oncolytic immunotherapies to break tumor resistance

  2016influential citation
• Immune outcomes in the liver: Is CD8 T cell fate determined by the environment?

  2015cites this paper
• Myeloid-derived suppressor cell impact on endogenous and adoptively transferred T cells.

  2015cites this paper
• Impaired T-Cell Function in B-Cell Lymphoma: A Direct Consequence of Events at the Immunological Synapse?

  2015influential citation